These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845 [TBL] [Abstract][Full Text] [Related]
4. Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1. Staib L; Link KH; Beger HG; J Gastrointest Surg; 2001; 5(3):275-81. PubMed ID: 11419451 [TBL] [Abstract][Full Text] [Related]
5. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant. Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043 [TBL] [Abstract][Full Text] [Related]
6. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D; Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival. Zaniboni A J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159 [TBL] [Abstract][Full Text] [Related]
8. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD). Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321 [TBL] [Abstract][Full Text] [Related]
9. North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer. O'Connell MJ Semin Oncol; 2001 Feb; 28(1 Suppl 1):4-8. PubMed ID: 11273589 [TBL] [Abstract][Full Text] [Related]
10. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627 [TBL] [Abstract][Full Text] [Related]
11. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973 [TBL] [Abstract][Full Text] [Related]
12. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01. Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G; J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010 [TBL] [Abstract][Full Text] [Related]
13. Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies. André T; Colin P; Louvet C; Gamelin E; Bouche O; Achille E; Colbert N; Boaziz C; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Billiau V; Buyse M; Gramont A; Semin Oncol; 2001 Feb; 28(1 Suppl 1):35-40. PubMed ID: 11273588 [TBL] [Abstract][Full Text] [Related]
14. A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results. Kerr DJ Semin Oncol; 2001 Feb; 28(1 Suppl 1):31-4. PubMed ID: 11273587 [TBL] [Abstract][Full Text] [Related]
16. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation. Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer. Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898 [TBL] [Abstract][Full Text] [Related]
18. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers. Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794 [TBL] [Abstract][Full Text] [Related]
19. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer. Reina JJ; Aparicio J; Salvador J; Pica JM; Rueda A; Lorenzo A; de la Puente CG; Borrega P; Moreno-Nogueira JA Cancer Chemother Pharmacol; 2003 Oct; 52(4):339-45. PubMed ID: 12851783 [TBL] [Abstract][Full Text] [Related]
20. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. O'Connell MJ; Mailliard JA; Kahn MJ; Macdonald JS; Haller DG; Mayer RJ; Wieand HS J Clin Oncol; 1997 Jan; 15(1):246-50. PubMed ID: 8996149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]